DAIC

OCTOBER 16, 2024

tim.hodson Wed, 10/16/2024 - 09:00 Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. Led by Dr. Pieter C. and 17.1%, respectively (P=0.02 for noninferiority).

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

DAIC

MARCH 8, 2024

milla1cf Fri, 03/08/2024 - 21:58 March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.

Stents 59

Stents Stent Anatomy Plaque 59

DAIC

JULY 2, 2024

mtaschetta-millane Tue, 07/02/2024 - 09:45 July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro Mission Drug Eluting Stent (DES). Diameters 2.25 mm to 3.00 mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5 mm and 4.0

Stents 105

Stents Stent Anatomy Technology 105

DAIC

JANUARY 31, 2024

GORE VIABAHN VBX Balloon Expandable Endoprosthesis milla1cf Wed, 01/31/2024 - 17:04 January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. No changes to the stent design were made to achieve the lower profile. Gore & Associates, Inc. Since its U.S.

Stents 111

Stents Stent Innovation Aortic 111

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:43 January 19, 2024 — W. While stenting is common when treating complex iliac occlusive disease, the question around whether to use a covered or bare metal stent remains a source of debate," said Prakash Krishnan, M.D. Gore & Associates, Inc.

Stents 107

Stents Stent Anatomy Outcomes 107

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. 2024 Jan, 17 (1) 1–13. The median follow-up period was 10.3 J Am Coll Cardiol Intv.

Stents 52

Stents Stent Cardiovascular Interventions Research 52

HCPLive

MARCH 1, 2024

The approval of the AGENT Drug-Coated Balloon is based on the AGENT IDE trial and was announced by Boston Scientific on March 01, 2024.

Stents 72

Stents Stent 72

DAIC

MARCH 1, 2024

milla1cf Fri, 03/01/2024 - 08:50 March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. vs. 28.7%; P=0.006).

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

Cardiology Update

JANUARY 7, 2024

Here is our curated list of the top interventional cardiology conferences and courses scheduled for 2024. Additionally, be sure to review the main general cardiology conferences listed in our Top 10 Cardiology Conferences for 2024. Noncoronary topics like structural heart disease and vascular medicine are also addressed.

Interventional Cardiology 64

Interventional Cardiology Innovation Heart Disease Physiology 64

CardiacWire

MARCH 29, 2025

With the FDA nod, Abbott can now evaluate the IVL system in treating severe calcification in coronary arteries prior to stenting. Notably, FastWaves FIH trial was successful last year, while Amplitudes Pulse IVL system secured its IDE approval in June of 2024.

Plaque 59

Plaque Interventional Cardiology Stents Stent 59

Journal of the American Heart Association

FEBRUARY 26, 2025

Stent performance was assessed.ResultsWe identified 28 patients (67.8% The procedures mostly used 7 Fr sheaths for stents on 6, 7, and 8 mm balloons and 8 Fr sheaths for 9, 10, 12 mm balloons. Median stent expansion percentage was 95% (IQR, 90%96%). Median stent shortening was 1.9% (IQR, 0%3.9%). kg (IQR, 9.116.4).

Stents 45

Stents Stent Stenosis Congenital 45

DAIC

MAY 30, 2024

Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). stent expansion at Maximum Calcium Site 96.7% stent expansion at Maximum Calcium Site 96.7% Shown here: Elixir Medical CEO Motasim Sirhan.

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

Circulation: Cardiovascular Interventions

JANUARY 15, 2024

Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013006, January 1, 2024. BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. P=0.15), 8.3 P=0.02), and 5.7

Stents 40

Stents Stent Myocardial Infarction Stenosis 40

DAIC

JUNE 18, 2024

Image courtesy: Getty Images christine.book Tue, 06/18/2024 - 11:07 June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. Stent Related Adverse Events greater than 1 Year After PCI.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MARCH 13, 2024

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Stents 116

Stents Stent Angioplasty Myocardial Infarction 116

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovascular diseases and related conditions. Suggest using MRAs before beta-blockers in cases of resistant hypertension. Explore 2024 ESC Updated Guidelines here.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

DAIC

APRIL 6, 2024

milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.

Heart Attack 78

Heart Attack Heart attacks Research Cholesterol 78

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).

Stents 45

Stents Stent Angioplasty Outcomes 45

Cardiometabolic Health Congress

JULY 17, 2024

The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health. Edwards EVOQUE Tricuspid Valve Replacement System (Approved: 02/01/2024) This system provides a novel approach to tricuspid valve replacement, potentially benefiting patients with tricuspid regurgitation without open-heart surgery.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144093-A4144093, November 12, 2024. Although stents are commonly used with over 3 million stents implanted in cardiovascular arteries every year, there have been minimal efforts to integrate sensing functionality with stents.

Stents 40

Stents Stent Circulation 40

Cardiology Update

APRIL 9, 2024

The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation). April 6, 2024. April 7, 2024.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP88-AWMP88, February 1, 2024. Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. Additionally, 10-15 ml of tirofiban were administered intravenously.

Stents 40

Stents Stent Angioplasty Stenosis 40

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2024

A total of 9,905 publications from 67 countries were published from 1 January 2014, to 1 March 2024. A total of 2,142 (29.52%) studies were from the United States, 1,293 (13.05%) were from China, and 919 (9.28%) were from the United Kingdom. Abdominal aortic aneurysm was the most frequently used author keyword (2,492).

Aneurysm 52

Aneurysm Aortic Research Download 52

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stents Stent Article 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

This study aimed to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

Stents 40

Stents Stent Plaque Article 40

DAIC

MAY 6, 2024

milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.

Congenital 105

Congenital Innovation VSD Stents 105

DAIC

APRIL 8, 2024

The study focused on patients who underwent PCI for acute coronary syndromes (ACS)—life-threatening conditions which include heart attacks and chest pain caused by decreased blood flow to the heart—with stents containing drugs to prevent further plaque buildup. Stents were supplied by Medtronic Corp. Minnesota, U.S.)

Heart Attack 111

Heart Attack Heart attacks Stents Stent 111

DAIC

APRIL 11, 2024

During PCI, an operator inserts a stent into a blocked artery through a catheter in the groin or arm. The stent is left in place, where it props the artery open to allow blood to flow freely; medications eluted by the stent can also help to prevent further plaque buildup.

Plaque 111

Plaque Heart Attack Heart attacks Coronary Artery Disease 111

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. The Avalus Ultra valve received FDA approval in January 2024 and is currently only commercially available in the United States.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP179-AWP179, February 1, 2024. In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment.

Stents 40

Stents Stent Thrombolysis Angioplasty 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145821-A4145821, November 12, 2024. In this hyperacute emergent clinical situation, covered stents have been considered as a primary measure to prevent further serious arterial events. A fabric-based covered graft stents yield poor clinical outcomes. at 2weeks, 26.1 at 1 year).Conclusion:The

Stents 40

Stents Stent Stenosis Outcomes 40

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Presented at Heart Valve Society 2024, Boston, MA. February 18–21, 2024. Eur J Cardiothorac Surg.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP174-ATP174, February 1, 2024.

Stents 40

Stents Stent Stenosis Strokes 40

DAIC

MARCH 28, 2025

For CCTA to be truly effective, the CT system must be designed to address the most difficult cardiac exams, including irregularities in heart rhythms, patients with limited cooperation, and those with calcification, stents or bypasses. 2024,November 8). 2012) 380:2095128. 10.1016/S0140-6736(12)61728-0. link] iv IMV.2023 v Walter, M.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP185-ATP185, February 1, 2024. Introduction:The Resolute Onyx stent has shown promise as an effective treatment for symptomatic intracranial atherosclerotic disease (sICAD), with positive clinical outcomes and low procedural complication rates.

Stents 40

Stents Stent Stenosis Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2024. Background:Studies have demonstrated that the addition of alteplase for patients with tandem lesions who underwent mechanical thrombectomy and acute stenting was safe with improved outcomes. of MT with carotid stenting alone (aOR 6.92 [0.45-105.7],

Stents 40

Stents Stent Outcomes Thrombolysis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP202-ATP202, February 1, 2024. Background:Advancements in arterial stenting technology have challenged prior notions favoring medical management over endovascular intervention for intracranial atherosclerotic disease (ICAD).

Stents 40

Stents Stent Technology Article 40